NantWorks   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: San Diego CA United States (2002)
Status: Acquired by ImmunityBio, Inc. (2020)

Organization Overview

First Clinical Trial
2006
NCT00646230
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Mergers & Acquisitions

Historical Acquisition Tree